Share Repurchase Program

Share Repurchase Program

Share Repurchase Program

BioNTech has entered into a share repurchase program, pursuant to which the Company may purchase American depositary shares (ADSs) in the amount of up to $1.5 billion over the next two years. BioNTech expects to use all or a portion of the ADSs to satisfy upcoming settlement obligations under the Company’s share-based payment arrangements. The timing and total amount of ADS repurchases will depend upon market conditions and may be made in open market purchases from time to time. The Program has been designed to operate within the safe harbor provided by Rule 10b-18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the affirmative defense provided by Rule 10b5-1 of the Exchange Act.

Press Releases

BioNTech Announces ADS Repurchase Program


Tranche 1

BioNTech announced on May 2, 2022 the start of the first tranche of its multi-year share buyback program announced in March 2022. The Company intends to repurchase own shares in an amount of up to $ 1 billion until November 2, 2022.

Announcement pursuant to Art. 5(1) a) of Regulation (EU) No. 596/2014 and Art. 2(1) of Delegated Regulation (EU) No. 2016/1052_Share Buyback Program 2022


Date Numbers of shares
Percentage of
share capital (1)
Average price
(in USD)
Purchased volume
(in USD)
Daily Totals
2022-05-02 - 2022-05-06 284,788 0.11 144.28 41,088,463.65 Details
2022-05-09 - 2022-05-13 273,500 0.11 149.04 40,762,373.37 Details
2022-05-16 - 2022-05-20 256,500 0.10 159.67 40,954,433.54 Details
Total 814,788 0.33 150.72 122,805,270.56  
(1) For the Share Buy-Back, the quota “Percentage of share capital” is calculated on the basis of the number of issued shares as of 2022-04-30: 248,552,200